EC Appoints VPH to key stakeholder group

The European Commission has appointed the Virtual Physiological Human Institute (VPHi) to its eHealth Stakeholder Group. With VPHi representing 50% of the...

EMA Regulation Vote result – major gains for in silico

On 10 March 2016 the European Parliament through an overwhelming majority, voted in favour of requiring the EMA to take into account alternative...

EMA PRIME scheme – room for improvement

On 07 March 2016, the European Medicines Agency (EMA) launched their new Priority Medicines Scheme (PRIME) which aims to accelerate assessment of innovative...

Over the Horizon 2020

Avicenna Alliance proclaims victory in EMA Regulation

The Avicenna Alliance, can claim a major victory in the revised EMA Regulation with the introduction of new text supporting modelling and...

EMA Regulation amendments call for framework for in silico

Amendments calling for the creation of a framework for in silico medicine have been tabled by MEP Martin Häusling (Greens/EFA, Germany) to...

US Legislature says FDA should use in silico methods

In an unprecedented victory for the in silico community in the US Congress has put forward a bill that “urges FDA to engage with device and drug...